Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Paz (115)

2024

  1. (, 10.2139/ssrn.4579870)

    Frontiers in Immunology

  2. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  3. CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis

    Frontiers in Immunology, Vol. 15

  4. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV

    The Journal of infectious diseases, Vol. 230, Núm. 2, pp. 421-425

  5. Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study

    The Lancet HIV, Vol. 11, Núm. 7, pp. e470-e478

2023

  1. A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model

    Journal of Bone and Mineral Research, Vol. 38, Núm. 10, pp. 1443-1452

  2. A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease

    Frontiers in Immunology, Vol. 14

  3. CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 9, pp. 1688-1696

  4. Controversies in the Design of Strategies for the Cure of HIV Infection

    Pathogens, Vol. 12, Núm. 2

  5. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

  6. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 20, pp. 18161-18171

  7. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

    Digestive Diseases and Sciences, Vol. 68, Núm. 6, pp. 2731-2737

  8. Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e116-e125

2022

  1. Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens

    Open Forum Infectious Diseases, Vol. 9, Núm. 7

  2. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  3. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

    Open Forum Infectious Diseases

  4. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  5. Effects of HIV Infection in Plasma Free Fatty Acid Profiles among People with Non-Alcoholic Fatty Liver Disease

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  6. Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

    Frontiers in Immunology, Vol. 13

  7. Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events

    eBioMedicine, Vol. 80